BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38633760)

  • 1. Heterogeneity and high prevalence of bone manifestations, and bone mineral density in congenital generalized lipodystrophy subtypes 1 and 2.
    Freire EBL; Brasil d'Alva C; Madeira MP; Lima GEDCP; Fernandes VO; Aguiar LB; Portella LB; Galvão Ozório R; Ponte CMM; Montenegro APDR; Montenegro Junior RM
    Front Endocrinol (Lausanne); 2024; 15():1326700. PubMed ID: 38633760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone imaging findings in genetic and acquired lipodystrophic syndromes: an imaging study of 24 cases.
    Teboul-Coré S; Rey-Jouvin C; Miquel A; Vatier C; Capeau J; Robert JJ; Pham T; Lascols O; Berenbaum F; Laredo JD; Vigouroux C; Sellam J
    Skeletal Radiol; 2016 Nov; 45(11):1495-506. PubMed ID: 27631079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone Density in Patients With Berardinelli-Seip Congenital Lipodystrophy Is Higher in Trabecular Sites and in Type 2 Patients.
    Lima JG; Nobrega LHC; Lima NN; Dos Santos MCF; Baracho MFP; Bandeira F; Capistrano L; Freire Neto FP; Jeronimo SMB
    J Clin Densitom; 2018; 21(1):61-67. PubMed ID: 27894728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel subtype of congenital generalized lipodystrophy associated with muscular weakness and cervical spine instability.
    Simha V; Agarwal AK; Aronin PA; Iannaccone ST; Garg A
    Am J Med Genet A; 2008 Sep; 146A(18):2318-26. PubMed ID: 18698612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seipin-linked congenital generalized lipodystrophy type 2: a rare case with multiple lytic and pseudo-osteopoikilosis lesions.
    Yamamoto A; Kusakabe T; Sato K; Tokizaki T; Sakurai K; Abe S
    Acta Radiol Open; 2019 Dec; 8(12):2058460119892407. PubMed ID: 31853371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal bone density and trabecular bone score, but high serum sclerostin in congenital generalized lipodystrophy.
    Lima JG; Nobrega LHC; Lima NN; Dos Santos MCF; Baracho MFP; Winzenrieth R; Bandeira F; Mendes-Aguiar CO; Neto FPF; Ferreira LC; Rosen CJ; Jeronimo SMB
    Bone; 2017 Aug; 101():21-25. PubMed ID: 28390904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone mineral density of the spine and femur in healthy Saudi females: relation to vitamin D status, pregnancy, and lactation.
    Ghannam NN; Hammami MM; Bakheet SM; Khan BA
    Calcif Tissue Int; 1999 Jul; 65(1):23-8. PubMed ID: 10369729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of disease characteristics of a large patient cohort with congenital generalized lipodystrophy from the Middle East and North Africa.
    Al Yaarubi S; Alsagheir A; Al Shidhani A; Alzelaye S; Alghazir N; Brema I; Alsaffar H; Al Dubayee M; Alshahrani A; Abdelmeguid Y; Omar OM; Attia N; Al Amiri E; Al Jubeh J; Algethami A; Alkhayyat H; Haleem A; Al Yahyaei M; Khochtali I; Babli S; Nugud A; Thalange N; Albalushi S; Hergli N; Deeb A; Alfadhel M
    Orphanet J Rare Dis; 2024 Mar; 19(1):118. PubMed ID: 38481246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misdiagnosis of Paget's Disease of Bone in a Congenital Generalized Lipodystrophy Patient: Case Report.
    Freire EBL; Madeira MP; Lima GEDCP; Fernandes VO; Aguiar LB; Fontenele JPU; Montenegro APDR; Marques TF; Ozório RG; d'Alva CB; Montenegro RM
    Front Endocrinol (Lausanne); 2021; 12():683697. PubMed ID: 34262529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital lipodystrophy induces severe osteosclerosis.
    Zou W; Rohatgi N; Brestoff JR; Zhang Y; Scheller EL; Craft CS; Brodt MD; Migotsky N; Silva MJ; Harris CA; Teitelbaum SL
    PLoS Genet; 2019 Jun; 15(6):e1008244. PubMed ID: 31233501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural History of Congenital Generalized Lipodystrophy: A Nationwide Study From Turkey.
    Akinci B; Onay H; Demir T; Ozen S; Kayserili H; Akinci G; Nur B; Tuysuz B; Nuri Ozbek M; Gungor A; Yildirim Simsir I; Altay C; Demir L; Simsek E; Atmaca M; Topaloglu H; Bilen H; Atmaca H; Atik T; Cavdar U; Altunoglu U; Aslanger A; Mihci E; Secil M; Saygili F; Comlekci A; Garg A
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2759-67. PubMed ID: 27144933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversations between insulin and bone: Potential mechanism of high bone density in patients with Berardinelli-Seip Congenital Lipodystrophy.
    Lima JG; Lima NN; Nobrega LH; Jeronimo SM
    Med Hypotheses; 2016 Dec; 97():94-97. PubMed ID: 27876139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone Mineral Density in Congenital Generalized Lipodystrophy: The Role of Bone Marrow Tissue, Adipokines, and Insulin Resistance.
    Freire EBL; d'Alva CB; Madeira MP; Lima GEDCP; Montenegro APDR; Fernandes VO; Montenegro Junior RM; Brazilian Group For The Study Of Inherited And Acquired Lipodystrophies Brazlipo
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic Acquired Osteosclerosis in a Middle-Aged Woman With Systemic Lupus Erythematosus.
    Guañabens N; Mumm S; Gifre L; Ruiz-Gaspà S; Demertzis JL; Stolina M; Novack DV; Whyte MP
    J Bone Miner Res; 2016 Sep; 31(9):1774-82. PubMed ID: 27005479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased bone mineral density in Costello syndrome.
    Leoni C; Stevenson DA; Martini L; De Sanctis R; Mascolo G; Pantaleoni F; De Santis S; La Torraca I; Persichilli S; Caradonna P; Tartaglia M; Zampino G
    Mol Genet Metab; 2014 Jan; 111(1):41-5. PubMed ID: 24246682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further delineation of AGPAT2 and BSCL2 related congenital generalized lipodystrophy in young infants.
    Liu Y; Li D; Ding Y; Kang L; Jin Y; Song J; Li H; Yang Y
    Eur J Med Genet; 2019 Sep; 62(9):103542. PubMed ID: 30266686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients.
    Ersoy FF; Passadakis SP; Tam P; Memmos ED; Katopodis PK; Ozener C; Akçiçek F; Camsari T; Ateş K; Ataman R; Vlachojannis JG; Dombros AN; Utaş C; Akpolat T; Bozfakioğlu S; Wu G; Karayaylali I; Arinsoy T; Stathakis PC; Yavuz M; Tsakiris JD; Dimitriades CA; Yilmaz ME; Gültekin M; Karayalçin B; Yardimsever M; Oreopoulos DG
    J Bone Miner Metab; 2006; 24(1):79-86. PubMed ID: 16369903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral content in patients with congenital generalized lipodystrophy is unaffected by metreleptin replacement therapy.
    Christensen JD; Lungu AO; Cochran E; Collins MT; Gafni RI; Reynolds JC; Rother KI; Gorden P; Brown RJ
    J Clin Endocrinol Metab; 2014 Aug; 99(8):E1493-500. PubMed ID: 25070319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic heterogeneity in body fat distribution in patients with congenital generalized lipodystrophy caused by mutations in the AGPAT2 or seipin genes.
    Simha V; Garg A
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5433-7. PubMed ID: 14602785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High bone mineral density in sickle cell disease: Prevalence and characteristics.
    De Luna G; Ranque B; Courbebaisse M; Ribeil JA; Khimoud D; Dupeux S; Silvera J; Offredo L; Pouchot J; Arlet JB
    Bone; 2018 May; 110():199-203. PubMed ID: 29428552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.